Immunotherapy Trials for Metastatic NSCLC FDA Pooled Analysis – The ASCO Post

In a U.S. Food and Drug Administration (FDA) pooled analysis reported in The Lancet Oncology, Bernardo Haddock Lobo Goulart, MD, and colleagues …